Ionis Pharmaceuticals Inc (STU:ISI)
€ 34.62 0.13 (0.38%) Market Cap: 5.44 Bil Enterprise Value: 4.45 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 59/100

Ionis Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Nov 29, 2022 / 02:40PM GMT
Release Date Price: €38.28 (-3.73%)
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

All right. Welcome, everyone. This is Josh Schimmer from Evercore ISI biotech team. Pleased to introduce management of Ionis Pharmaceuticals to our Fifth Annual Healthcare Conference. We have Onaiza Cadoret, Executive Vice President, Chief Global Product Strategy and Operations Officer -- sorry, Chief Global Product Strategy & Operations Officer; and Eugene Schneider, Executive Vice President and Chief Clinical Development Officer. So thanks so much for joining. There's so many moving parts that Ionis' had to talk about. So, I thought maybe we'd spend some time on the recent announcement of the Metagenomi partnership and just thinking about the strategy there and then maybe dive into some of the more later-stage emerging clinical programs.

Questions & Answers

Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst

So maybe just start with. So Ionis hosted a call to discuss the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot